NSE filing, NSE: MONOPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Mono Pharmacare Ltd: key numbers
- Share price
- ₹9.30
- Market cap
- ₹16.43 Cr
- Revenue (annual)
- ₹165.7 Cr
- Net profit (annual)
- ₹0.73 Cr
- P/E (TTM)
- 22.4×Sector 46.1×
- Promoter holding
- 56.72%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mono Pharmacare Ltd
All →Mono Pharmacare Other Announcement
Mono Pharmacare notified non-applicability of its Q1 FY27 corporate governance report under Reg 27(2). As an SME-listed entity, it is exempt under Reg 15(2)(b) of SEBI LODR.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited held its Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, auditor appointment, and related party transactions.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.
Mono Pharmacare Legal & Regulatory
Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.
- Value
- ₹0.02 Cr
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.
Mono Pharmacare Board Meeting Outcome
Mono Pharmacare Limited's board meeting approved the re-appointment of a director, the appointment of new statutory auditors, and the scheduling of the company's 4th AGM.
Other other announcement announcements
All →Lexora Global Other Announcement
Lexora Global Ltd informed BSE of its updated company website address. The change from www.lexoragloble.com to www.lexoraglobal.in is purely administrative.
Refractory Shapes Other Announcement
Refractory Shapes Ltd filed its Integrated Governance filing for the quarter and half year ended 30 Sep 2026. It claims exemption from the Corporate Governance Report and reported zero investor grievances.
Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.